The combinatorial actions of serine, threonine, and tyrosine kinases are involved in the regulation of information transfer within and between cells (6, 19) . In general, a hierarchy of functions has evolved for these different kinases such that growth and differentiation factor receptors receive extracellular signals and transmit these across the plasma membrane in the form of a tyrosine phosphorylation event. Downstream of the growth factor-receptor interaction is the activation by tyrosine phosphorylation of a number of cytoplasmic and nuclear serine/threonine kinases which are thought to be secondary effectors of the primary signal. There are, however, clear examples of variations to this theme. Nuclear isoforms of tyrosine kinases are known to exist (8, 43) , and tyrosine phosphorylation of nuclear pro- teins has been demonstrated (3) . The activin growth factor receptor appears to be the first example of a mammalian transmembrane kinase which phosphorylates serine/threonine rather than tyrosine residues (28) .
We have been involved in the cloning of novel tyrosine kinases from embryonic and transformed cells by screening Xgtll expression libraries with antibodies to phosphotyrosine. While a number of kinases which exclusively phosphorylate tyrosine residues (23, 25, 26) have been identified in this way, we have also isolated cDNAs encoding serine/ threonine/tyrosine (STY) kinases (4, 18) .
Here we report the characterization of one of these kinases, the Esk kinase, and show that it exists in two isoforms, one of which appears to be a transmembrane molecule.
MATERIALS AND METHODS
Isolation of cDNA clones. Expression libraries were constructed from P19 embryonal carcinoma (EC) cells (18) as well as from CB7 and DP28-9 erythroleukemia cell lines (4) by using poly(A)+ RNA and screened for active protein * Corresponding author. tyrosine kinases with use of an antiphosphotyrosine antibody. Essentially, 5 x 105 plaques were screened by infecting the bacterial strain Y1090 with recombinant bacteriophage and incubating the cells at 42°C for 4 to 6 h. The plates were then overlayed with filters presoaked in 10 mM isopropyl-o-D-thiogalactopyranoside (IPTG) and incubated for an additional 6 h at 37°C. Positive clones were identified by probing the filters with antiphosphotyrosine monoclonal antibody PY20 (ICN Biomedicals) and an alkaline phosphatase-conjugated anti-mouse secondary antibody.
Sequencing of cDNA clones. The esk cDNA inserts were subcloned into the EcoRI site of plasmid PTZ19R (Pharmacia). Nested deletions were generated by using an Exo-Mung deletion kit (Stratagene). Double-stranded DNA sequencing was carried out on the deletion mutants by using the dideoxy-chain termination method (36) .
P19 EC cell maintenance and differentiation. P19 EC cells were cultured and differentiated as described previously (21, 29) . Essentially, P19 cells were induced to differentiate into cells of the neural or muscle lineage by aggregating the cells in bacterial dishes in the presence of 0.5 ,uM retinoic acid or 1% dimethyl sulfoxide for 3 days and subsequently plating the cells onto coated tissue culture dishes to form monolayers in the absence of inducing drug.
RNA isolation and Northern (RNA) blot analysis. Total RNA was prepared from cells or tissues as described by Auffray and Rougeon (2) . Poly(A)+ RNA was selected by passage of total RNA through oligo(dT)-cellulose columns as described by Jacobson (20 assays. The reaction products were resolved on SDS-10% polyacrylamide gels, and the dried gels were exposed to Kodak XAR-5 X-ray film. Phosphoproteins were electroeluted for phosphoamino acid analysis by the method of Edwards et al. (9) .
(iii) Renaturation kinase assay. The procedure was carried out essentially as described by Ferrell and Martin (11 PAP treatment was an adaptation of the procedure described by Morrison et al. (31) . Membrane strips prepared as described above were incubated with 80 ,g of PAP per ml in a reaction buffer containing 20 mM Tris (pH 7.4), 5% glycerol, 0.05% Triton X-100, 2.5 mM MgCl2, aprotinin (2 p,g/ml), and leupeptin (5 ,ug/ml) for 1 h at 37°C with gentle shaking. An additional amount of PAP enzyme (80 ,g/ml) was added, and the mixture was incubated for 1 h at 37°C. In some experiments, 1 mM ammonium vanadate was added to the buffer to inhibit phosphatase activity. The reaction was stopped by blocking the blots with 20% serum in Tris-saline for 1 h at room temperature. The blots were probed with an antiphosphotyrosine antibody as described above and detected by using an 1251I-labelled anti-mouse secondary antibody).
Isolation of the GST-PTP1B fusion protein. An overnight culture of E. coli DHSa(pGEX-PTPlB) was diluted 1:10 (with 100 p,g of ampicillin per ml), grown for 1 h at 37°C, and induced for another hour by addition of IPTG to 1 mM. Bacteria were sonicated three times for 20 s each time in lysis buffer containing 10 mM imidazole-HCl (pH 7.2), 1 mM EDTA, 100 mM NaCl, 1 mM dithiothreitol, and 1% Triton X-100. Lysates were cleared by centrifugation, and the supernatants were incubated with 500 ,lI of 50% glutathionecoupled beads (Pharmacia) for 30 min at 4°C. The GST-PTP1B fusion was eluted twice with 1 ml of 5 mM reduced glutathione (Boehringer Mannheim) in phosphatase buffer. Glycerol was added to a final concentration of 33% (vol/vol), and aliquots of the enzyme (150 ,ul of PTP1B per ml of reaction buffer) were used in phosphatase experiments as described above.
STY kinase assay and phosphatase (GST-PTIP`1B) treatment. TrpE-STY fusion protein was prepared as described by Howell et al. (18) . The STY fusion protein was immunoprecipitated with an anti-TrpE antibody (Oncogene Science) and allowed to autophosphorylate in the presence of [_y-32P]ATP for 30 min at room temperature. The reaction products were resolved on SDS-10% polyacrylamide gels and transferred to an Immobilon P membrane, and individual strips were treated with PTP1B as described above.
Nucleotide sequence accession number. The GenBank accession number for the murine esk-1 cDNA sequence is M86377. 
RESULTS
Identification and expression of the esk gene product. mRNA isolated from P19 murine EC cells (21) was used to prepare a Xgtl1 cDNA library, which was then screened with antibodies to phosphotyrosine as described previously (4, 18, 26) . A 2.97-kb cDNA isolated in this way was shown by sequence analysis to encode a novel protein kinase (see below) which we have named Esk (EC STY kinase).
To investigate the expression pattern of esk, Northern blot analysis was performed on a number of adult mouse tissues and cell lines. esk appears as a 3.0-kb mRNA (size estimated from rRNA markers) in cells which contain a significant subpopulation of proliferating cells (Fig. 1 ). Organs such as brain, heart, lung, and kidney had low amounts of esk mRNA, while testes, bone marrow, spleen, and thymus all contained higher levels of esk mRNA. The myeloma cell line SP10 and the B-cell leukemia lines L1210 and 70Z/3 also expressed a 3.0-kb esk mRNA. It appears, therefore, that esk transcripts are expressed in a limited spectrum of cell types with some capacity for proliferation. Following differentiation of P19 EC cells (21, 29) into the neuronal (using retinoic acid) or muscle (using dimethyl sulfoxide) lineage, esk mRNA levels remained constant (Fig. 2) . During the time course of differentiation, there remains a significant proportion of proliferating cells (21, 28a) , and we believe that it is these cells that express the esk transcripts.
Two distinct esk kinase isoforms are expressed in P19 cells. The nucleotide and deduced amino acid sequences of the 2.97-kb esk cDNA are presented in Fig. 3 . The first methionine codon in the longest open reading frame is located at position 38, with a purine in the -3 position and a guanine residue in the +4 position, consistent with the consensus sequence of Kozak (24) . No amino acids ending in a TGA termination codon at nucleotide 2606. It is followed by a 362-nucleotide 3' untranslated region containing a potential polyadenylation signal (AAT AAA at position 2901) which ends in 46 consecutive adenosine residues.
Analysis of the predicted translation product of the esk open reading frame revealed several interesting features. As expected, the Esk protein contains the 11 subdomains which are thought to collectively make up the catalytic region of protein kinases (16) . Surprisingly, although the Esk kinase was cloned by virtue of its immunoreactivity with an antiphosphotyrosine antibody, comparison with the NBRF-PIR(r) data base by using the Lipman-Pearson algorithm (27) showed that its catalytic domain shows greatest similarity to serine/threonine kinases, including the yeast Snfl serine/ threonine kinase (7) (27% identity over a 402-amino-acid overlap), calcium/calmodulin-dependent protein kinase (40) (28% identity over 543 amino acids), and the human pim protein kinase (46) (25% over 329 amino acids). When individual subdomains were searched against the data base, an interesting homology was observed between Esk and a group of kinases that have STY kinase activity (4, 10, 18, 37) . For convenience, we will refer to these bifunctional VOL. 12, 1992 on 
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kinases as members of the STY family of enzymes. It has been suggested by Seger et al. (37) that the homology in subdomain XI may be related to the novel specificity that these enzymes share. In this subdomain, Esk resembles the STY/Clk enzyme (4, 18) and Erk-1, a member of the erk kinase family (37) (Fig. 4) (Fig. Sa) . Cells transfected with the expression vector containing esk in the antisense orientation did not contain any immunoreactive proteins. This immunoreactivity was specific for phosphotyrosine, since phosphoserine and phosphothreonine did not compete for antibody binding, whereas phosphotyrosine completely abolished Esk immunoreactivity with the antiphosphotyrosine antibody (data not shown). When the same antibody was used for immunoprecipitation followed by an in vitro kinase assay, a 75-kDa protein was again identified, while control cells were negative (Fig. Sb) . To rule out the possibility that Esk phosphorylation in these immunoprecipitates resulted from a coprecipitating bacterial kinase, in situ kinase reactions were performed. Essentially, Esk bacterial extracts were resolved on SDS-gels, transferred to Immobilon membranes, renatured and then incubated with [-y-32P]ATP as described previously (11) . As with the immunoblots and immunoprecipitates, a 75-kDa band was identified in Esk bacterial extracts but was absent in extracts prepared from bacteria expressing the antisense expression vector (Fig. Sc) . Phosphoamino acid analysis was performed on Esk protein labelled in immunoprecipitates or following renaturation, and only phosphoserine and phosphothreonine residues were identified (Fig. 6) . Although the Esk protein is immunoreactive with antiphosphotyrosine antibodies, only phosphoserine and phosphothreonine residues were labelled in these in vitro conditions.
Phosphatase treatment of Esk. Since the Esk kinase was immunoreactive with antiphosphotyrosine antibodies yet displayed no in vitro tyrosine kinase activity, we were concerned about the specificity of the antiphosphotyrosine antibody. Previously, others had reported that certain monoclonal antiphosphotyrosine antibodies cross-react with 5'-mononucleotides and with phosphohistidine, phosphoserine, and phosphothreonine residues (12) . In view of this observation, phosphatase treatment of the Esk kinase was performed in an attempt to identify the residues responsible for its immunoreactivity. If the Esk kinase reacted with the antibody via a phosphotyrosine residue, then specific phosphotyrosine phosphatase treatment should abolish its immunoreactivity. Conversely, if Esk immunoreactivity was due to some other epitope, phosphatase treatment would not affect antibody binding. In the following experiments, Eskcontaining extracts were resolved on SDS-gels, electroblotted onto nitrocellulose membranes, and then treated with either PAP or the human PTP1B (expressed as a GST fusion protein). Preparations of PAP are known to have reactivity toward phosphoserine, phosphothreonine, and phosphotyrosine, while PTP1B preferentially dephosphorylates phosphotyrosine residues (42) . The filters were then reacted with antibodies to phosphotyrosine and 125I-labelled secondary antibodies. As shown in Fig. 7a (4, 18) . Like Esk, the STY kinase lost its immunoreactivity with the antiphosphotyrosine antibody when treated with PTP1B (Fig. 7b) . To further define the specificity of the phosphatase, the TrpE-STY fusion protein was immunoprecipitated and incubated with [_y-32P]ATP in a kinase assay as previously described (18) . The products of the kinase reaction were run on SDS-gels, transferred to Immobilon, and treated with PTP1B. The samples were acid hydrolyzed, and phosphoamino acids were resolved by two-dimensional thin-layer electrophoresis. From Fig. 8, it ration used in these experiments removes phosphate groups from tyrosine but not serine or threonine residues. These results confirm that Esk contains a phosphotyrosine residue(s) which was not detected in our initial in vitro or renaturation kinase assays.
Esk has serine, threonine, and tyrosine kinase activities. In the preceding experiments, kinase reactions were performed in a lysis buffer containing salt and detergents supplemented with magnesium (see Materials and Methods). We therefore attempted to define the buffer conditions that might reveal Esk tyrosine kinase activity in vitro. Kinase assays were carried out in a series of buffers (HEPES, MES, and Tris) at different pH conditions supplemented with magnesium and/or manganese. We found that the Esk kinase had optimum activity in buffers ranging between pH 6.5 and 7.0 containing 2 mM manganese. Under these conditions, Esk was able to autophosphorylate and phosphorylate exogenous substrates on serine, threonine, and tyrosine residues. The results of one such experiment are shown in Fig. 9 . In  Fig. 9a , it is evident that Esk not only can autophosphorylate (lane 2) but also has activity toward myelin basic protein (lane 4) and enolase (lane 6). Immunoprecipitates from extracts of bacteria expressing antisense esk mRNA lacked kinase activity (lanes 1, 3, and 5 ). Amino acid analysis of the phosphorylated products (Fig. 9B) revealed that threonine was the preferred target in all three substrates, although phosphotyrosine and phosphoserine were also present. Taken together, the results obtained from Western blotting, the phosphatase experiments, and the in vitro kinase assays clearly demonstrate that the Esk kinase has serine, threonine, and tyrosine kinase activities and is therefore a novel member of the STY family of protein kinases.
DISCUSSION
Several protein kinases appear to exist in multiple isoforms encoded by distinct mRNA species. In this regard, Esk represents a novel departure from previously identified alternatively spliced kinases in that Esk is the first example of a kinase which may exist both as a transmembrane molecule and as a soluble catalytically active enzyme. Indeed, most alternative splicing events in receptor protein kinases generate molecules with variant ligand binding affinities or specificities as for the fibroblast growth factor, Ltk, and activin receptors (1, 15, 17) . Alternatively, these splicing events have also been shown to generate a truncated receptor in the case of the neurogenic TrkB kinase or for the epidermal growth factor receptor, truncated and secreted (30, 32) .
The cloned esk cDNAs do not encode an amino-terminal signal peptide, and it remains possible that the putative transmembrane domain is itself the signal peptide (44) . Indeed, the signals which determine the subcellular localization of proteins are incompletely understood and are likely encoded in the three-dimensional structure of the protein (44) . Furthermore, there appears to be a hierarchy of subcellular localization signals (34) , and thus insertion of a transmembrane domain in the Esk-1 protein may override the localization signals shared between Esk-1 and Esk-2.
To date, only one mammalian transmembrane kinase, the activin receptor, is believed to have serine/threonine instead of tyrosine kinase activity (28) . Despite the high degree of homology between Esk and members of the serine/threonine kinase family, and we have found very little sequence homology between Esk and the activin receptor. Two other transmembrane serine/threonine kinases, Daf-1 from Caenorhabditis elegans and Zmpkl from maize, also have very little homology to Esk (14, 45) . Through the recent cloning of these novel serine/threonine receptor kinases (14, 28, 45) Amino acid sequence comparisons revealed that Esk shares greatest homology with members of the serine/threonine family of protein kinases, and in particular with the catalytic domains of the yeast kinases Snfl and Niml+ (7, 35) . Seger et al. (37) have recently reported that conserved amino acid motifs exist in subdomain XI of a family of kinases with the capacity to phosphorylate serine, threonine, and tyrosine residues. Since this region is generally not well conserved among kinases, it was suggested that it may play some role in determining substrate specificity. Both Esk and Niml+ show considerable homology to the STY kinases in this region; however, they have a more pronounced homology to each other. The similarity of this domain in the Esk and Niml+ kinases may reflect conserved biochemical activities for these two enzymes.
Threonine and tyrosine phosphorylation events are important in regulating the activity of several signal transduction components. The activities of the epidermal growth factor receptor kinase, the cell cycle-regulating kinase p34cdc2, and the MAP kinases have all been shown to be regulated through threonine and tyrosine phosphorylation events (13, 33, 38) . Since Esk appears to exist as both a transmembrane and soluble catalytically active enzyme, its threonine and VOL. 12, 1992 . 
